(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE BINDING SITE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

THE BINDING SITE

ST13

US500000077331874

Class

1, 5, 9, 10

Filing

77331874

Registration

3479719

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

51

Latest update

09/10/2025

Trademark type

Combined

Nice classes

1, 5, 9, 10

Filing date

11/16/2007

Registration date

08/05/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/15/2017

Last transaction

09/10/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1989-00-00

First use in commerce

1989-00-00

Drawing code

3

Owner type

03

Owner location

Birmingham, GB

Examiner

BAKER,JORDAN A

Law office

L20

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of two hands black, holding a yellow globe; enclosed in the globe in black are stylized maps of the United Kingdom and Ireland; a rectangular base is featured below the hands; the body of the base is in yellow with a black outline, and the base features the black wording "THE BINDING SITE"; the entire mark is surrounded by a narrow white boarder and a thin black line.

Holders and representatives

Holders

THE BINDING SITE GROUP, LTD.
The Binding Site, Ltd

Representatives

Kenya Williams Thermo Fisher Scientific

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic kits comprised of diagnostic reagents for laboratory usecalibratorsreagent platesbuffered solutionsdiluent solutionsserum; Reagentsdiagnostic reagentsbiological reagentshistology reagentsenzyme radioimmunoassay reagentsimmunoassay reagentsantigen substratesantibodies for scientific research use; and test kits comprised of reagentsbufferscalibratorsdiluentsantibodiesantigen substratesconjugatesstopping solutionsantisera and/or dropper bottles for scientific and research use using bloodbody fluidsbody tissues or extracts thereof; Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Chemicalsbuffer and standard solutions used in analytical chemistry; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic preparations used in science; Diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; Reagents for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; electrophoresis gels other than for medical or veterinary purposes

Class 5

Calibrating solutionsdiluentscontrol samplesreagentsantibodiesantigen substratesconjugatesstopping solutionsimmunofluorescence reagentshistology reagentsenzyme immunoassay reagents and general purpose reagents for medical and veterinary diagnostic and clinical use; and diagnostic and immunological test kits consisting of reagentscontrolsbufferscalibratorsdiluentsantibodiesantigen substratesconjugatesstopping solutionsantisera and/or dropper bottlesall for use in measuring the concentration of proteinsantibodiesantigens and other substances in bloodother body fluids and body tissuesextracts thereoffor use in the diagnosistreatmentcureprevention or mitigation of diseases and other conditions in humans and animals; biological and chemical preparations and reagents for medical or veterinary use; Clinical medical reagents; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for medical and veterinary use; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; medical diagnostic kits for use in electrophoresisimmunology and serologyconsisting primarily of extracts from blood or body fluids; control solutions indicative of a positive result for medical use; buffer solutions for diluting samples and/or reagents for medical use; reagentsblood reagents; electrophoretic gels for medical purposes; protein stainfor visualizing resultsfor medical purposes; antisera for precipitating specific proteinsfor medical purposes; fixative for precipitating proteinsfor medical purposes; templates for controlling the application of samples and/or antiserafor medical purposes; blotting paper and blotting tissues for removing excess liquid for gelsfor medical purposes

Class 9

Apparatus for testing gasliquids and solids; and electronic apparatus for electrophysiological measurement and testing of cells; blank magnetic data carriers; computer software for use in data manipulation and instrument control for use in measuring the concentration of proteinsantibodiesantigens and other substances in body fluids for use in the diagnosistreatmentpreventioncure and mitigation of diseases and other conditions in humans; and nephelometers for use in measuring the concentration of proteinsantibodiesantigens and other substances in body fluids for use in the diagnosistreatmentpreventioncure and mitigation of diseases and other conditions in humans; electronic and computerized radial immunodiffusion plate readers; electrophoresis tank and power supplyfor laboratory use; gel presses for pressing and drying gels; laboratory equipmentincubators

Class 10

Medical diagnostic apparatus and instruments for the diagnosistreatment and cure of diseases in humansmultiple myelomalymphocytic neoplasmsWaldenstrom's macroglobulinemiaamyloidosislight chain deposition diseases and connective tissues diseasessystemic lupus erythematosus; apparatus for bloodurine and serum analysis; apparatus for clinical diagnosis; apparatus used in implementing diagnostic tests designed to detect abnormalities in bloodserum and urineautomated clinical analyzers based on colorimetric and turbidmetric measurementsdiluentsreagentscalibratorscontrol serum; and medical diagnostic apparatus and analytical apparatus for medical purposes

Publications

History of USPTO decisions and trademark events.

51 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/12/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/26/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/26/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/26/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/26/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/15/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/15/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/15/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/15/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

08/07/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/05/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/22/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/22/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/22/2013

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

08/05/2013

E815

TEAS SECTION 8 & 15 RECEIVED

08/05/2013

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

08/31/2011

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/15/2011

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/15/2011

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/08/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

08/05/2008

PUBO

PUBLISHED FOR OPPOSITION

05/20/2008

NPUB

NOTICE OF PUBLICATION

04/30/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/16/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/15/2008

XAEC

EXAMINER'S AMENDMENT ENTERED

04/15/2008

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/15/2008

GNEA

EXAMINERS AMENDMENT E-MAILED

04/15/2008

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/15/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/15/2008

GNRT

NON-FINAL ACTION E-MAILED

04/15/2008

CNRT

NON-FINAL ACTION WRITTEN

04/15/2008

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

04/15/2008

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

04/04/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/27/2008

ALIE

ASSIGNED TO LIE

03/27/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/12/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/04/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/04/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/04/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/01/2008

GNRT

NON-FINAL ACTION E-MAILED

03/01/2008

CNRT

NON-FINAL ACTION WRITTEN

03/01/2008

DOCK

ASSIGNED TO EXAMINER

03/01/2008

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

11/21/2007

NWAP

NEW APPLICATION ENTERED

11/20/2007

Continuous trademark protection

Get notified about every new filing that threatens THE BINDING SITE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.